Lobbying23ANDME lobbying by quarter
23ANDME's latest lobbying report covers Q3 2023, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Medical/Disease Research/Clinical Labs and Consumer Issues/Safety/Protection.
23ANDME
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $33K | 2 |
| Q1 2023 | $20K | 2 |
| Q2 2023 | $0 | 1 |
| Q3 2023 | $0 | 1 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Medical research and clinical labs$40K · 2 reports
- Consumer protection and safety$13K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES2 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| W Strategies | $40K | 2 quarters |
| Ipolicy Solutions | $13K | 4 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JENNIFER RACHEL LEIB | Fellow, Senate Committee on Health, Education, Labor, and Pensions | Q4 2022 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 23/10/23for Q2 2023 | Ipolicy Solutions | Under $5,000 |
| 23/10/16for Q3 2023 | Ipolicy Solutions | Under $5,000 |
| 23/07/17for Q1 2023 | W Strategies | $20K |
| 23/07/10for Q2 2023 | Ipolicy Solutions | Under $5,000 |
| 23/04/20for Q1 2023 | W Strategies | $20K |
| 23/04/17for Q1 2023 | Ipolicy Solutions | Under $5,000 |
| 23/01/19for Q4 2022 | W Strategies | $20K |
| 23/01/03for Q4 2022 | Ipolicy Solutions | $13K |